Thoraco-laparoscopic Partial Esophagogastrectomy for Management of Esophageal Cancer
Early and Intermediate Term Outcomes of Thoraco-laparoscopic Partial Esophagogastrectomy for Management of Esophageal Cancer
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: ahmed m salah eldin, assistant lecturer of general
- Phone Number: +201001329315
- Email: ahmed_mohamed2@med.sohag.edu.eg
Study Locations
-
-
-
Sohag, Egypt
- Sohag faculty of medicine
-
Contact:
- ahmed m salah eldin, assistant lecturer
- Phone Number: +201001329315
- Email: ahmed_mohamed2@med.sohag.edu.eg
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients diagnosed with resectable esophageal cancer (stages I-III).
- Suitable for thoraco-laparoscopic partial esophagogastrectomy.
- Eastern Cooperative Oncology Group (ECOG) performance status 0-2.
Exclusion Criteria:
- Presence of distant metastasis at diagnosis.
- History of previous esophageal or gastric surgery.
- Contraindications to laparoscopy or thoracoscopy.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Thoraco-laparoscopic partial esophagogastrectomy
Patients diagnosed with resectable esophageal cancer will undergo thoraco-laparoscopic partial esophagogastrectomy
|
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Immediate Postoperative complications
Time Frame: first month post operative
|
30-day morbidity and mortality (using Clavien-Dindo classification)
|
first month post operative
|
|
Dysphagia
Time Frame: Collected at base line preoperative,one month, and 12 months post-surgery.
|
yes or no
|
Collected at base line preoperative,one month, and 12 months post-surgery.
|
|
resection margin status
Time Frame: 2 weeks postoperative
|
resection margin status (R0/R1/R2)
|
2 weeks postoperative
|
|
lymph node yield.
Time Frame: first month post operative
|
number of lymph nodes in specimen
|
first month post operative
|
|
regurgitation
Time Frame: Collected at one month, and 12 months post-surgery.
|
yes or no
|
Collected at one month, and 12 months post-surgery.
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
recurrence rate
Time Frame: first year post operative
|
first year post operative
|
|
body mass index
Time Frame: Collected at base line preoperative,one month, and 12 months post-surgery.
|
Collected at base line preoperative,one month, and 12 months post-surgery.
|
|
serum albumin
Time Frame: Collected at base line preoperative,one month, and 12 months post-surgery.
|
Collected at base line preoperative,one month, and 12 months post-surgery.
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Study record dates
Study Major Dates
Study Start (Estimated)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- Soh-Med-25-2-5MD
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.